Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$15,939,463
+$572,032 QoQ
Shares Held
1,146,724
+3.0% QoQ
Ownership
1.88%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. JANX ranks #136 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in JANX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $15,939,463 | 1,146,724 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $15,367,431 | 1,113,582 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $26,489,635 | 1,083,864 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $20,843,407 | 902,312 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $21,084,543 | 780,909 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $38,278,743 | 714,956 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $30,101,645 | 662,594 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,143,715 | 624,104 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $17,603,144 | 467,547 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $4,379,878 | 408,190 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,898,984 | 386,804 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,477,660 | 377,225 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $4,290,478 | 354,585 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,475,126 | 339,797 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,529,414 | 334,521 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,463,000 | 283,620 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $3,946,812 | 275,231 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $4,350,997 | 220,527 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $4,582,964 | 211,880 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $549,324 | 22,017 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||